The Christie NHS Foundation Trust
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.christie.nhs.uk/
Clinical Trials
119
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (77 trials with phase data)• Click on a phase to view related trials
To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway
- Conditions
- Metastatic Spinal Cord Compression
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 72
- Registration Number
- NCT06965101
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma
- Conditions
- Abdominal Neuroblastoma
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT06804447
Enabling Genomic Testing in Cancer of Unknown Primary
- Conditions
- Cancer of Unknown PrimaryNeoplasm, Unknown Primary
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT06695494
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
🇬🇧The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
🇬🇧Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom
Chronic Radiation Induced Bowel Toxicity Study
- Conditions
- Prostate Cancer
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT06640959
- Locations
- 🇬🇧
Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
🇬🇧Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, United Kingdom
Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy
- Conditions
- Nasopharyngeal CancerNasopharyngeal CarcinomaEpstein-Barr VirusHead and Neck Cancer
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT06480903
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
Novel LION Trial Combines Anti-inflammatory Drug with Immunotherapy to Combat Advanced Cancers
The groundbreaking LION trial investigates the combination of celecoxib with immunotherapy to treat advanced triple-negative breast cancer, non-small cell lung cancer, and renal cell carcinoma.
Global Trial Aims to Improve Outcomes for Stage IV Non-Small Cell Lung Cancer
The TOURIST trial, the world's largest of its kind, is recruiting nearly 1,000 patients with stage IV non-small cell lung cancer (NSCLC) to assess the benefits of radiotherapy.
The Alarm's Mike Peters Achieves Remission from Richter's Syndrome Through NHS Drug Trial
Mike Peters, frontman of The Alarm, achieved remission from aggressive Richter's syndrome after participating in an NHS drug trial at The Christie in Manchester.
NHS Launches Personalised Cancer Vaccine Program Across England with Thousands Expected to Enroll
The NHS Cancer Vaccine Launch Pad program will provide personalised mRNA vaccines to thousands of cancer patients across 30 hospitals in England to prevent disease recurrence.